Publications by authors named "Susan D Richman"

Claim this Profile
P
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trial.
Russell Frood, Alexandra Gilbert, Duncan Gilbert, Natalie L Abbott, Susan D Richman

BMJ Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The colorectal liver metastasis growth pattern phenotype is not dependent on genotype.
Diederik J Höppener, Sanne M L Verheul, Pieter M H Nierop, Florian E Buisman, Boris Galjart, Susan D Richman

Br J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed Digital PCR Reference Gene Measurement for Genomic and Cell-Free DNA Analysis.
Dilek Yener, Eloise J Busby, Jo Vandesompele, Gertjan Wils, Susan D Richman

Cells· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.
Alexandra Gilbert, Richard Adams, Joanne Webster, Duncan C Gilbert, Natalie L Abbott, Susan D Richman

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis.
Connor E Woolley, Enric Domingo, Juan Fernandez-Tajes, Kathryn A F Pennel, Patricia Roxburgh, Susan D Richman

Mol Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial.
Christopher J M Williams, Richard Gray, Robert K Hills, Michael Shires, Liping Zhang, Susan D Richman

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testing.
Kanishta Srihar, Arief Gusnanto, Susan D Richman, Nicholas P West, Leanne Galvin

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures.
Umair Mahmood, Andrew Blake, Sanjay Rathee, Leslie Samuel, Graeme Murray, Susan D Richman

Cancer Res Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge, Shania M Corry, Natalie C Fisher, Susan D Richman

Nat Genet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy.
Maxime W Lafarge, Enric Domingo, Korsuk Sirinukunwattana, Ruby Wood, Leslie Samuel, Susan D Richman

NPJ Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge, Shania M Corry, Natalie C Fisher, Susan D Richman

Nat Genet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.
Christopher J M Williams, Faye Elliott, Nancy Sapanara, Faranak Aghaei, Liping Zhang, Susan D Richman

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study.
Sophia J Wagner, Daniel Reisenbüchler, Nicholas P West, Jan Moritz Niehues, Jiefu Zhu, Susan D Richman

Cancer Cell· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing.
Susan D Richman, Gemma Hemmings, Helen Roberts, Niall Gallop, Rachel Dodds

J Clin Pathol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study.
Jan Moritz Niehues, Philip Quirke, Nicholas P West, Heike I Grabsch, Marko van Treeck, Susan D Richman

Cell Rep Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.
Shania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, Niamh A Leonard, Natalie C Fisher, Susan D Richman

Gut· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
Louise C Brown, Janet Graham, David Fisher, Richard Adams, Jenny Seligmann, Susan D Richman

Clin Trials· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR Amplification in Metastatic Colorectal Cancer.
Giovanni Randon, Rona Yaeger, Jaclyn F Hechtman, Paolo Manca, Giovanni Fucà, Susan D Richman

J Natl Cancer Inst· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.
Richard A Adams, David J Fisher, Janet Graham, Jenny F Seligmann, Matthew Seymour, Susan D Richman

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of WEE1 Is Effective in - and -Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.
Jenny F Seligmann, David J Fisher, Louise C Brown, Richard A Adams, Janet Graham, Susan D Richman

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
Sanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, David Fisher, Tim R de Back, Susan D Richman

Br J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in Wild-Type Metastatic Colorectal Cancer.
Christopher J M Williams, Jenny F Seligmann, Faye Elliott, Michael Shires, Susan D Richman

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA.
Thomas L Dunwell, Simon C Dailey, Anine L Ottestad, Jihang Yu, Philipp W Becker, Susan D Richman

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Sudhir B Malla, David J Fisher, Enric Domingo, Andrew Blake, Sylvana Hassanieh, Susan D Richman

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis